PINK1–Associated Mitophagy Protects Against Cisplatin–Induced Ototoxicity by Regulating the Subcellular Distribution of ACSL4
Cells · 2026
DOI: 10.3390/cells15181657 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Ting Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan…. Hauptthemen laut MEDLINE: Cisplatin, Mitophagy, Coenzyme A Ligases, Ototoxicity. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Hubei Province Project.
Abstract (Originalsprache)
Cisplatin–induced ototoxicity is a significant clinical issue linked to ferroptosis and mitophagy dysfunction. This study investigated how mitophagy regulates ferroptosis in cisplatin–induced hearing loss using cultured primary rat cochlear marginal cells in vitro and a C57BL/6J mouse model of cisplatin–induced ototoxicity in vivo. Cisplatin suppressed the PTEN–induced putative kinase 1 (PINK1) pathway, impaired mitophagy, and triggered ferroptosis characterized by iron overload, lipid peroxidation, increased acyl–CoA synthetase long–chain family member 4 (ACSL4), and decreased glutathione peroxidase 4. Pharmacological activation of mitophagy or PINK1 overexpression alleviated ferroptosis in vitro, while deferoxamine treatment reduced cisplatin–induced hearing loss and blood–labyrinth barrier damage in vivo. Mechanistically, restoration of mitophagy was associated with increased mitochondrial targeting and reduced cytosolic accumulation of ACSL4, potentially through mitophagic clearance, thereby suppressing ferroptosis. These findings support a model in which impaired PINK1–associated mitophagy contributes to cytosolic ACSL4 accumulation and ferroptotic injury. Modulating mitophagy and ACSL4 subcellular distribution may represent a potential strategy for mitigating cisplatin–induced ototoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
- Institute of Otorhinolaryngology-Head and Neck Surgery, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
- Hubei Province Clinical Research Center for Deafness and Vertigo, Wuhan 430022, China.
ORCID-Profile: Shimin Zong, Hongjun Xiao
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Hubei Province Project
Zitieren
APA
Li, T., Yu, W., Wan, H., Yu, X., Lian, X., Zhou, Z., Zong, S., & Xiao, H. (2026). PINK1–Associated Mitophagy Protects Against Cisplatin–Induced Ototoxicity by Regulating the Subcellular Distribution of ACSL4. Cells. https://doi.org/10.3390/cells15181657
Vancouver
Li T, Yu W, Wan H, Yu X, Lian X, Zhou Z, et al. PINK1–Associated Mitophagy Protects Against Cisplatin–Induced Ototoxicity by Regulating the Subcellular Distribution of ACSL4. Cells. 2026. doi:10.3390/cells15181657
BibTeX
@article{Li2026,
author = {Li, Ting and Yu, Wenting and Wan, Huanzhi and Yu, Xuan and Lian, Xi and Zhou, Ziqi and Zong, Shimin and Xiao, Hongjun},
title = {PINK1–Associated Mitophagy Protects Against Cisplatin–Induced Ototoxicity by Regulating the Subcellular Distribution of ACSL4},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15181657}
}
EUVIMED